GB0301395D0 - Inflammatory disorder treatment - Google Patents

Inflammatory disorder treatment

Info

Publication number
GB0301395D0
GB0301395D0 GBGB0301395.0A GB0301395A GB0301395D0 GB 0301395 D0 GB0301395 D0 GB 0301395D0 GB 0301395 A GB0301395 A GB 0301395A GB 0301395 D0 GB0301395 D0 GB 0301395D0
Authority
GB
United Kingdom
Prior art keywords
inflammatory disorder
disorder treatment
treatment
inflammatory
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0301395.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aston University
Original Assignee
Aston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aston University filed Critical Aston University
Priority to GBGB0301395.0A priority Critical patent/GB0301395D0/en
Publication of GB0301395D0 publication Critical patent/GB0301395D0/en
Priority to PCT/GB2004/000173 priority patent/WO2004064823A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
GBGB0301395.0A 2003-01-21 2003-01-21 Inflammatory disorder treatment Ceased GB0301395D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0301395.0A GB0301395D0 (en) 2003-01-21 2003-01-21 Inflammatory disorder treatment
PCT/GB2004/000173 WO2004064823A1 (en) 2003-01-21 2004-01-21 Ceramide derivatives for the treatment of inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0301395.0A GB0301395D0 (en) 2003-01-21 2003-01-21 Inflammatory disorder treatment

Publications (1)

Publication Number Publication Date
GB0301395D0 true GB0301395D0 (en) 2003-02-19

Family

ID=9951541

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0301395.0A Ceased GB0301395D0 (en) 2003-01-21 2003-01-21 Inflammatory disorder treatment

Country Status (2)

Country Link
GB (1) GB0301395D0 (en)
WO (1) WO2004064823A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1022443C2 (en) 2003-01-20 2004-07-22 Tno Sphingolipids for improving the composition of the intestinal flora.
WO2004064820A2 (en) 2003-01-20 2004-08-05 Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels
WO2005084657A1 (en) 2004-03-02 2005-09-15 Mcgill University Compositions and methods for preventing or treating an inflammatory response
EP2065040A3 (en) * 2004-06-29 2009-09-09 Jado Technologies GmbH Sphingolipids against pathological processes in lipid rafts
EP1618876A1 (en) * 2004-07-19 2006-01-25 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Use of sphingolipids for prevention and treatment of atherosclerosis
DE102004052697A1 (en) * 2004-10-29 2006-05-04 Haehner, Thomas, Dr. Pharmaceutical preparations for the treatment of alcohol abuse, hepatitis, pancreatitis, Alzheimer's disease, Parkinson's disease, diabetes, toxic kidney disease, reperfusion damage, arteriosclerosis and as an antidote to environmental toxins and drug intoxication
JP2008521888A (en) 2004-11-30 2008-06-26 ネーデルランドセ オルガニサティエ フォール トエゲパストナトールヴェテンシャッペリク オンデルゾエク ティエヌオー Sphingolipids in the treatment and prevention of steatosis or hepatotoxicity and its sequelae
WO2008006046A1 (en) 2006-07-06 2008-01-10 Case Western Reserve University Ceramide composition and use thereof in treatment of ocular diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100639531B1 (en) * 1997-12-05 2006-10-27 코스모페름 베.파우 Compositions comprising a combination of a free sphingoid base and a ceramid and methods of manufacturing same
CA2320117A1 (en) * 1998-02-12 1999-08-19 Emory University Sphingolipid derivatives and their methods of use
JP2000086601A (en) * 1998-09-04 2000-03-28 Otsuka Pharmaceut Co Ltd Ceramide derivative
JP2003528851A (en) * 2000-03-28 2003-09-30 ザ リポソーム カンパニー、インコーポレーテッド Ceramide derivatives and methods of use

Also Published As

Publication number Publication date
WO2004064823A1 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
EP1689485A4 (en) Cardioelectromagnetic treatment
AP2006003818A0 (en) Wastewater treatment
GB0326486D0 (en) Combination treatment
GB0312407D0 (en) Treatment
GB2430002B (en) Well treatment
IL173068A0 (en) Acute inflammatory condition treatment
GB0301395D0 (en) Inflammatory disorder treatment
AU152617S (en) Section
GB0401495D0 (en) Well treatment system
GB0314557D0 (en) Improved reduction calculations
GB0301686D0 (en) Cage
EP1773360A4 (en) Acute inflammatory condition treatment
GB0426141D0 (en) Treatment
GB0424085D0 (en) Well treatment
EP1603513A4 (en) Treatment using dantrolene
GB0323078D0 (en) Sewage treatment
GB0325838D0 (en) Wastewater treatment
GB0304531D0 (en) Treatment
GB0307740D0 (en) Treatment
GB0303430D0 (en) Treatment methods
GB0315322D0 (en) Treatment methods
GB2400846B (en) Sewage treatment
GB0412411D0 (en) Treatment
GB0413584D0 (en) Well treatment
GB0311430D0 (en) Electrofusible units

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)